Clinical Trial, FDA Approval, User Metrics Misrepresentation Suits Filed
(October 17, 2016, 12:20 PM EDT) -- Recent securities class action and shareholder derivative lawsuits filed in federal courts across the country include complaints alleging misrepresentation of clinical trial results for a bladder cancer treatment drug, growth in...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login